undefined undefined
NaN.000
NaN.00%
Even though Foghorn Therapeutics Inc. (NASDAQ:FHTX) has fallen by 31% over the ...
04-19 19:43
Foghorn Therapeutics (NASDAQ:FHTX) on Tuesday announced that Kristian Humer would join the company as CFO. Humer joins Foghorn with over 14 years of diversified financial strategy and business develop...
04-16 19:25
BMO Capital analyst Etzer Darout has maintained their bullish stance on FHTX st...
04-10 19:06
An update from Foghorn Therapeutics (FHTX) is now available. Foghorn Therapeuti...
04-10 04:52
Wedbush analyst Robert Driscoll reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform and maintains $13 price target.
03-08 23:08
Foghorn Therapeutics (NASDAQ:FHTX) reported its Q4 earnings results on Thursday...
03-07 22:05
Foghorn Therapeutics Reports FY23 Collaboration Revenue Of $34.2M Vs $19.2M A Y...
03-07 08:16
Despite an already strong run, Foghorn Therapeutics Inc. (NASDAQ:FHTX) shares h...
02-15 06:53
北京时间2024年02月09日04时52分,Moderna Inc(MRNA.us)股票出现异动,股价快速跳水5.09%。截至发稿,该股报94.25美元/股,成...
02-09 04:52
Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
02-09 00:48